secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2023-08-31T23:59:59+00:00
Accession:  0001213900-23-072602
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma files PCT patent for Alzheimer's treatment using prucalopride and ketamine
--------------------------------------------------------------------------------

- PCT patent application filed on August 25, 2023, for methods treating Alzheimer's disease.
- Treatment combines prucalopride (5-HT4 agonist) with ketamine (NMDA antagonist).
- Application seeks international patent protection; no granted status or trial data reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023072602/0001213900-23-072602-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023072602/ea184484-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-072602

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer